[{"drug":"http://www.wikidata.org/entity/Q416632","drugLabel":"nefazodone","drugClass":"","drugFunction":"selective serotonin reuptake inhibitor, adrenergic uptake inhibitors, second-generation antidepressive agents","chemicalFormula":"C₂₅H₃₂ClN₅O₂","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Nefazodone.svg","proteinInteraction":"Solute carrier family 6 member 2, Solute carrier family 6 member 4, Cytochrome P450 family 3 subfamily A member 4, 5-hydroxytryptamine receptor 2A","otherDiseaseTreated":"post-traumatic stress disorder, mental depression, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q422244","drugLabel":"fluoxetine","drugClass":"","drugFunction":"selective serotonin reuptake inhibitor, second-generation antidepressive agents, Cytochrome P-450 CYP2D6 Inhibitors","chemicalFormula":"C₁₇H₁₈F₃NO","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Fluoxetin%20Structural%20Formulae%20of%20both%20enantiomers.png","proteinInteraction":"Solute carrier family 6 member 4, 5-hydroxytryptamine receptor 2B, Anoctamin 1, Solute carrier family 29 member 4, Potassium inwardly-rectifying channel, subfamily J, member 6","otherDiseaseTreated":"mental disorder, anxiety, obsessive-compulsive disorder, bulimia, mood disorders, post-traumatic stress disorder, anxiety disorder, panic disorder, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q411932","drugLabel":"duloxetine","drugClass":"","drugFunction":"selective serotonin reuptake inhibitor, adrenergic uptake inhibitors","chemicalFormula":"C₁₈H₁₉NOS","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Duloxetine.png","proteinInteraction":"5-hydroxytryptamine receptor 2A, Solute carrier family 6 member 2, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 6, Solute carrier family 6 member 4","otherDiseaseTreated":"migraine, anxiety, arthritis, obsessive-compulsive disorder, mood disorders, post-traumatic stress disorder, fibromyalgia, anxiety disorder, generalized anxiety disorder, postpartum depression, peripheral neuropathy, mental disorder, major depressive disorder, complex regional pain syndrome, osteoarthritis susceptibility 1"},{"drug":"http://www.wikidata.org/entity/Q221174","drugLabel":"topiramate","drugClass":"","drugFunction":"anticonvulsant agent, anti-obesity medication, neuroprotective agent","chemicalFormula":"C₁₂H₂₁NO₈S","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Topiramate.svg","proteinInteraction":"Carbonic anhydrase 4, Carbonic anhydrase 12, Carbonic anhydrase 7, Carbonic anhydrase 1","otherDiseaseTreated":"epilepsy, pain, bipolar disorder, migraine, mood disorders, post-traumatic stress disorder, essential tremor, tonic–clonic seizure, focal epilepsy, migraine with aura, infantile epileptic encephalopathy, intracranial hypertension"},{"drug":"http://www.wikidata.org/entity/Q411188","drugLabel":"aripiprazole","drugClass":"","drugFunction":"antipsychotics, atypical antipsychotic","chemicalFormula":"C₂₃H₂₇Cl₂N₃O₂","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Aripiprazole.svg","proteinInteraction":"5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 1B, Histamine receptor H1, 5-hydroxytryptamine receptor 2A, Dopamine receptor D2","otherDiseaseTreated":"Alzheimer's disease, mental disorder, schizophrenia, dementia, anxiety, psychosis, obsessive-compulsive disorder, mood disorders, Tourette syndrome, post-traumatic stress disorder, borderline personality disorder, personality disorder, schizoaffective disorder"},{"drug":"http://www.wikidata.org/entity/Q319877","drugLabel":"alprazolam","drugClass":"benzodiazepine","drugFunction":"anxiolytic, GABAA receptor positive allosteric modulators, hypnotics and sedatives, GABA Modulators","chemicalFormula":"C₁₇H₁₃ClN₄","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Alprazolam%20structure.svg","proteinInteraction":"Gamma-aminobutyric acid type A receptor subunit alpha1, Gamma-aminobutyric acid type A receptor subunit alpha5, Gamma-aminobutyric acid type A receptor subunit alpha3, Gamma-aminobutyric acid type A receptor subunit alpha2","otherDiseaseTreated":"anxiety, agoraphobia, post-traumatic stress disorder, anxiety disorder, panic disorder, generalized anxiety disorder, insomnia, substance abuse, neurotic disorder, sleep-wake disorder"},{"drug":"http://www.wikidata.org/entity/Q408535","drugLabel":"quetiapine","drugClass":"atypical antipsychotic","drugFunction":"serotonin antagonist, H1 antagonist, alpha blocker, dopamine antagonist","chemicalFormula":"C₂₁H₂₅N₃O₂S","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Quetiapine.svg","proteinInteraction":"5-hydroxytryptamine receptor 2A, Dopamine receptor D2, Solute carrier family 6 member 2, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 1F, Histamine receptor H1","otherDiseaseTreated":"Alzheimer's disease, mental disorder, autism, dementia, bipolar disorder, anxiety, psychosis, obsessive-compulsive disorder, mood disorders, post-traumatic stress disorder, borderline personality disorder, personality disorder, anxiety disorder, schizoaffective disorder, generalized anxiety disorder, insomnia, schizophreniform disorder, substance abuse, sleep-wake disorder"},{"drug":"http://www.wikidata.org/entity/Q407988","drugLabel":"clonazepam","drugClass":"benzodiazepine","drugFunction":"anticonvulsant agent, GABAA receptor positive allosteric modulators, GABA Modulators","chemicalFormula":"C₁₅H₁₀ClN₃O₃","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Clonazepam.svg","proteinInteraction":"Gamma-aminobutyric acid type A receptor subunit alpha2, Gamma-aminobutyric acid type A receptor subunit alpha1, Gamma-aminobutyric acid type A receptor subunit alpha3","otherDiseaseTreated":"generalized anxiety disorder, restless legs syndrome, insomnia, transient tic disorder, childhood absence epilepsy, early myoclonic encephalopathy, Myoclonic epilepsy, sleep-wake disorder, schizophrenia, epilepsy, bipolar disorder, anxiety, post-traumatic stress disorder, dysarthria, anxiety disorder, panic disorder"},{"drug":"http://www.wikidata.org/entity/Q408471","drugLabel":"paroxetine","drugClass":"","drugFunction":"selective serotonin reuptake inhibitor, second-generation antidepressive agents, Cytochrome P-450 CYP2D6 Inhibitors","chemicalFormula":"C₁₉H₂₀FNO₃","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Paroxetine%20Structural%20Formulae%20V.1.svg","proteinInteraction":"Solute carrier family 6 member 4","otherDiseaseTreated":"anxiety, obsessive-compulsive disorder, post-traumatic stress disorder, Social Anxiety Disorder, eating disorder, anxiety disorder, panic disorder, generalized anxiety disorder, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q412443","drugLabel":"risperidone","drugClass":"","drugFunction":"alpha blocker, dopamine antagonist, serotonin antagonist, antipsychotics, H1 antagonist","chemicalFormula":"C₂₃H₂₇FN₄O₂","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Risperidone%20Structural%20Formulae%20V.1.svg","proteinInteraction":"5-hydroxytryptamine receptor 6, Dopamine receptor D3, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 1B, Histamine receptor H1, 5-hydroxytryptamine receptor 2A, Dopamine receptor D2, Adrenoceptor alpha 1A, Adrenoceptor alpha 1B, Adrenoceptor alpha 1D, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 7","otherDiseaseTreated":"autism, schizophrenia, dementia, bipolar disorder, anxiety, intermittent explosive disorder, psychosis, obsessive-compulsive disorder, intellectual disability, Alzheimer's disease, mood disorders, Tourette syndrome, post-traumatic stress disorder, personality disorder, anxiety disorder, conduct disorder, schizoaffective disorder, impulse control disorder, mental disorder, oppositional defiant disorder, insomnia, pervasive developmental disorder, sleep-wake disorder, bipolar I disorder"},{"drug":"http://www.wikidata.org/entity/Q423757","drugLabel":"escitalopram","drugClass":"(RS)-citalopram","drugFunction":"selective serotonin reuptake inhibitor","chemicalFormula":"C₂₀H₂₁FN₂O","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Escitalopram.svg","proteinInteraction":"Solute carrier family 6 member 4","otherDiseaseTreated":"anxiety, obsessive-compulsive disorder, post-traumatic stress disorder, anxiety disorder, generalized anxiety disorder, substance abuse, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q425296","drugLabel":"prazosin","drugClass":"","drugFunction":"antihypertensive drug, alpha blocker, adrenergic alpha-1 receptor antagonists","chemicalFormula":"C₁₉H₂₁N₅O₄","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Prazosin.svg","proteinInteraction":"Adrenoceptor alpha 1A, Adrenoceptor alpha 1B, Adrenoceptor alpha 1D, Adrenoceptor alpha 2C, Adrenoceptor alpha 2A, Adrenoceptor alpha 2B","otherDiseaseTreated":"arterial hypertension, post-traumatic stress disorder, prostatic hypertrophy, Raynaud disease, urinary retention"},{"drug":"http://www.wikidata.org/entity/Q407617","drugLabel":"sertraline","drugClass":"","drugFunction":"antidepressant, selective serotonin reuptake inhibitor","chemicalFormula":"C₁₇H₁₇Cl₂N","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Sertraline.svg","proteinInteraction":"Solute carrier family 6 member 4","otherDiseaseTreated":"mental disorder, obsessive-compulsive disorder, post-traumatic stress disorder, eating disorder, anxiety disorder, panic disorder, generalized anxiety disorder, postpartum depression, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q409672","drugLabel":"(RS)-citalopram","drugClass":"medication","drugFunction":"selective serotonin reuptake inhibitor, second-generation antidepressive agents","chemicalFormula":"C₂₀H₂₁FN₂O","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Citalopram.svg","proteinInteraction":"Solute carrier family 6 member 4","otherDiseaseTreated":"mental disorder, dementia, anxiety, obsessive-compulsive disorder, mood disorders, post-traumatic stress disorder, anxiety disorder, generalized anxiety disorder, substance abuse, diabetic polyneuropathy, alcohol abuse, nicotine dependence, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q409672","drugLabel":"(RS)-citalopram","drugClass":"nitrile","drugFunction":"selective serotonin reuptake inhibitor, second-generation antidepressive agents","chemicalFormula":"C₂₀H₂₁FN₂O","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Citalopram.svg","proteinInteraction":"Solute carrier family 6 member 4","otherDiseaseTreated":"mental disorder, dementia, anxiety, obsessive-compulsive disorder, mood disorders, post-traumatic stress disorder, anxiety disorder, generalized anxiety disorder, substance abuse, diabetic polyneuropathy, alcohol abuse, nicotine dependence, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q409672","drugLabel":"(RS)-citalopram","drugClass":"organofluorine","drugFunction":"selective serotonin reuptake inhibitor, second-generation antidepressive agents","chemicalFormula":"C₂₀H₂₁FN₂O","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Citalopram.svg","proteinInteraction":"Solute carrier family 6 member 4","otherDiseaseTreated":"mental disorder, dementia, anxiety, obsessive-compulsive disorder, mood disorders, post-traumatic stress disorder, anxiety disorder, generalized anxiety disorder, substance abuse, diabetic polyneuropathy, alcohol abuse, nicotine dependence, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q409672","drugLabel":"(RS)-citalopram","drugClass":"tertiary amine","drugFunction":"selective serotonin reuptake inhibitor, second-generation antidepressive agents","chemicalFormula":"C₂₀H₂₁FN₂O","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Citalopram.svg","proteinInteraction":"Solute carrier family 6 member 4","otherDiseaseTreated":"mental disorder, dementia, anxiety, obsessive-compulsive disorder, mood disorders, post-traumatic stress disorder, anxiety disorder, generalized anxiety disorder, substance abuse, diabetic polyneuropathy, alcohol abuse, nicotine dependence, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q409672","drugLabel":"(RS)-citalopram","drugClass":"benzodihydrofuran","drugFunction":"selective serotonin reuptake inhibitor, second-generation antidepressive agents","chemicalFormula":"C₂₀H₂₁FN₂O","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Citalopram.svg","proteinInteraction":"Solute carrier family 6 member 4","otherDiseaseTreated":"mental disorder, dementia, anxiety, obsessive-compulsive disorder, mood disorders, post-traumatic stress disorder, anxiety disorder, generalized anxiety disorder, substance abuse, diabetic polyneuropathy, alcohol abuse, nicotine dependence, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q898407","drugLabel":"venlafaxine","drugClass":"","drugFunction":"selective serotonin reuptake inhibitor, adrenergic uptake inhibitors","chemicalFormula":"C₁₇H₂₇NO₂","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Venlafaxine%20flat.svg, http://commons.wikimedia.org/wiki/Special:FilePath/Venlafaxine%20structure.svg","proteinInteraction":"Solute carrier family 6 member 4, Solute carrier family 6 member 2","otherDiseaseTreated":"autism, pain, migraine, anxiety, obsessive-compulsive disorder, attention deficit hyperactivity disorder, post-traumatic stress disorder, borderline personality disorder, chronic fatigue syndrome, fibromyalgia, anxiety disorder, generalized anxiety disorder, neurotic disorder"},{"drug":"http://www.wikidata.org/entity/Q410412","drugLabel":"carbamazepin","drugClass":"anticonvulsant agent","drugFunction":"non-opioid analgesic, antimanic agents, cytochrome P-450 CYP3A inducers, anticonvulsant agent","chemicalFormula":"C₁₅H₁₂N₂O","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Carbamazepine.svg","proteinInteraction":"","otherDiseaseTreated":"post-traumatic stress disorder, temporal lobe epilepsy, restless legs syndrome, trigeminal neuralgia, tonic–clonic seizure, complex partial seizure, schizophrenia, epilepsy, bipolar disorder, mood disorders"},{"drug":"http://www.wikidata.org/entity/Q410346","drugLabel":"lamotrigine","drugClass":"anticonvulsant agent","drugFunction":"calcium channel blocker, anticonvulsant agent, excitatory amino acid antagonist, Voltage-Gated Sodium Channel Blockers","chemicalFormula":"C₉H₇Cl₂N₅","chemicalStructure":"http://commons.wikimedia.org/wiki/Special:FilePath/Lamotrigine.svg","proteinInteraction":"","otherDiseaseTreated":"mental disorder, epilepsy, bipolar disorder, migraine, anxiety, mood disorders, post-traumatic stress disorder, borderline personality disorder, temporal lobe epilepsy, trigeminal neuralgia, neurological disorder, focal epilepsy, visual epilepsy"}]